CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-30 | Springate Wayne S. SR VP of Operations | Grant or award · Options to buy Common Stock | +4,264 | $0.44 | $2K | 4,264 |
| 2017-06-30 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +4,738 | $0.44 | $2K | 4,738 |
| 2017-06-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +14,212 | $0.44 | $6K | 14,212 |
| 2017-06-15 | Rodino Peter W. III Exec Dir Govt Relations/Secrty | Grant or award · Options to buy Common Stock | +6,632 | $0.44 | $3K | 6,632 |
| 2017-06-15 | Springate Wayne S. Sr VP of Operations | Grant or award · Options to buy Common Stock | +4,264 | $0.44 | $2K | 4,264 |
| 2017-06-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +4,738 | $0.44 | $2K | 4,738 |
| 2017-06-15 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +17,287 | $0.44 | $8K | 17,287 |
| 2017-06-15 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +17,287 | $0.44 | $8K | 17,287 |
| 2017-06-15 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +17,287 | $0.44 | $8K | 17,287 |
| 2017-06-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +14,293 | $0.44 | $6K | 14,293 |
| 2017-06-15 | Rodino Peter W. III Exec Dir Govt Relations/Secrty | Grant or award · Options to buy Common Stock | +6,671 | $0.44 | $3K | 6,671 |
| 2017-06-15 | Springate Wayne S. Sr VP of Operations | Grant or award · Options to buy Common Stock | +4,288 | $0.44 | $2K | 4,288 |
| 2017-06-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +4,765 | $0.44 | $2K | 4,765 |
| 2017-06-08 | Equels Thomas K. CEO / President | Other acquisition · Options to buy Common Stock | +300,000 | 495,833 | ||
| 2017-05-31 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +14,361 | $0.53 | $8K | 14,361 |
| 2017-05-31 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +14,361 | $0.53 | $8K | 14,361 |
| 2017-05-31 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +14,361 | $0.53 | $8K | 14,361 |
| 2017-05-15 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +13,238 | $0.57 | $8K | 13,238 |
| 2017-05-15 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +13,238 | $0.57 | $8K | 13,238 |
| 2017-05-15 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +13,238 | $0.57 | $8K | 13,238 |
Page 18 of 19 · 376 trades